ArticleBMJ open2023

Study design and rationale of EXPLORER-CN: a phase III, randomised, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of mavacamten in Chinese adults with symptomatic obstructive hypertrophic cardiomyopathy.

Zhuang Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.